Keyphrases
Bunyavirus
100%
Broad-spectrum Activity
100%
Cap-dependent Endonuclease Inhibitor
100%
Cap-dependent Endonuclease
50%
Influenza Virus
33%
Drug-resistant Virus
33%
Lymphocytic Choriomeningitis Virus
33%
Mechanism of Action
16%
Pregenomic RNA (pgRNA)
16%
Public Health Risk
16%
Inhibitory Mechanism
16%
Survival Rate
16%
Therapeutic Potential
16%
Human Infection
16%
Disease Severity
16%
Antiviral Activity
16%
Amino Acid Substitution
16%
Clinical Utility
16%
Antiviral Drugs
16%
Disease Burden
16%
Infected Mice
16%
Ribavirin
16%
Helix
16%
Viral Hemorrhagic Fever
16%
Improved Survival
16%
Hemorrhagic Disease
16%
Lassa Virus
16%
Influenza-like Illness
16%
RNA Transcription
16%
Viral Load
16%
Side Chain
16%
Junin Virus
16%
Thrombocytopenia
16%
Carboxyl Group
16%
Hepatic Dysfunction
16%
Severe Influenza
16%
Whole Genome Sequencing
16%
Drug Selection
16%
Structural Compounds
16%
Influenza Virus Replication
16%
Inhibitor Compound
16%
Bunyavirales
16%
Cap-snatching
16%
Inhibitor Library
16%
Immunology and Microbiology
Bunyaviridae
100%
Influenza Virus
50%
Lymphocytic Choriomeningitis Virus
33%
Virus
33%
Survival Rate
16%
Viral Replication
16%
Hemorrhagic Fever
16%
Influenza
16%
Antiviral Activity
16%
Amino Acid Substitution
16%
Viral Load
16%
Disease Burden
16%
Lassa Virus
16%
Drug Mechanism
16%
Junin Virus
16%
RNA Transcription
16%
Whole Genome Sequencing
16%
Ribavirin
16%
Infection
16%
In Vitro
16%